Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Drug Makers Slow To Join Consolidation Bandwagon

This article was originally published in PharmAsia News

Executive Summary

While drug makers in other countries engage in mergers and acquisitions, their Indian colleagues see consolidation as a few years away. Although the movement may be slower, consolidation is expected in India as firms led by their entrepreneurs become vulnerable to such a move. But one industry official said that just one successful deal could spark more. A company is seen vulnerable if its promoter holds less than a majority interest. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068179

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel